Kahn RS - Search Results

1

Efficacy and tolerance of D-cycloserine in drug-free schizophrenic patients.

van Berckel BN, Hijman R, van der Linden JA, Westenberg HG, van Ree JM, Kahn RS. van Berckel BN, et al. Among authors: kahn rs. Biol Psychiatry. 1996 Dec 15;40(12):1298-300. doi: 10.1016/S0006-3223(96)00311-3. Biol Psychiatry. 1996. PMID: 8959296 Clinical Trial. No abstract available.

2

Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.

Davidson M, Kahn RS, Powchik P, Warne P, Losonczy MF, Kaminsky R, Apter S, Jaff S, Davis KL. Davidson M, et al. Among authors: kahn rs. Arch Gen Psychiatry. 1991 Jan;48(1):73-6. doi: 10.1001/archpsyc.1991.01810250075011. Arch Gen Psychiatry. 1991. PMID: 1670618

3

Brief neuroleptic discontinuation and clinical symptoms in Kraepelinian and non-Kraepelinian chronic schizophrenic patients.

Harvey PD, Putnam KM, Davidson M, Kahn RS, Powchik P, McQueeney R, Keefe RS, Davis KL. Harvey PD, et al. Among authors: kahn rs. Psychiatry Res. 1991 Sep;38(3):285-92. doi: 10.1016/0165-1781(91)90018-k. Psychiatry Res. 1991. PMID: 1684442

4

The MCPP challenge test in schizophrenia: hormonal and behavioral responses.

Iqbal N, Asnis GM, Wetzler S, Kahn RS, Kay SR, van Praag HM. Iqbal N, et al. Among authors: kahn rs. Biol Psychiatry. 1991 Oct 15;30(8):770-8. doi: 10.1016/0006-3223(91)90233-c. Biol Psychiatry. 1991. PMID: 1751620 Clinical Trial.

5

Psychopharmacology of anxiety disorders: on the role of serotonin in the treatment of anxiety states and phobic disorders.

Westenberg HG, den Boer JA, Kahn RS. Westenberg HG, et al. Among authors: kahn rs. Psychopharmacol Bull. 1987;23(1):145-9. Psychopharmacol Bull. 1987. PMID: 3110855 Clinical Trial. No abstract available.

6

Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine.

den Boer JA, Westenberg HG, Kamerbeek WD, Verhoeven WM, Kahn RS. den Boer JA, et al. Among authors: kahn rs. Int Clin Psychopharmacol. 1987 Jan;2(1):21-32. doi: 10.1097/00004850-198701000-00002. Int Clin Psychopharmacol. 1987. PMID: 3117876 Clinical Trial.

7

L-5-hydroxytryptophan in the treatment of anxiety disorders.

Kahn RS, Westenberg HG. Kahn RS, et al. J Affect Disord. 1985 Mar-Apr;8(2):197-200. doi: 10.1016/0165-0327(85)90046-1. J Affect Disord. 1985. PMID: 3157732

8

Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo.

Kahn RS, Westenberg HG, Verhoeven WM, Gispen-de Wied CC, Kamerbeek WD. Kahn RS, et al. Int Clin Psychopharmacol. 1987 Jan;2(1):33-45. doi: 10.1097/00004850-198701000-00003. Int Clin Psychopharmacol. 1987. PMID: 3312397 Clinical Trial.

9

Non-opiate beta-endorphin fragments and dopamine--I. The neuroleptic-like gamma-endorphin fragments interfere with the behavioural effects elicited by small doses of apomorphine.

Van Ree JM, Innemee H, Louwerens JW, Kahn RS, De Wied D. Van Ree JM, et al. Among authors: kahn rs. Neuropharmacology. 1982 Nov;21(11):1095-101. doi: 10.1016/0028-3908(82)90166-6. Neuropharmacology. 1982. PMID: 6184639

10

Clinical, biochemical, and hormonal aspects of treatment with Des-tyr1-gamma-endorphin in schizophrenia.

Verhoeven WM, van Ree JM, Westenberg HG, Krul JM, Brouwer GJ, Thijssen JH, de Wied D, van Praag HM, Ceulemans DL, Kahn RS. Verhoeven WM, et al. Among authors: kahn rs. Psychiatry Res. 1984 Apr;11(4):329-46. doi: 10.1016/0165-1781(84)90006-4. Psychiatry Res. 1984. PMID: 6204351 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,144 results

Search Page

Filters